Merck (MRK) Reiterated at Neutral by Cantor Fitzgerald
June 2, 2026 7:23 AM
Cantor Fitzgerald analyst Carter Gould reiterated a Neutral rating and $120.00 price target on Merck (NYSE: MRK).The analyst commented, "Sac-TMT’s ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
